JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1981) 88, 173-180    DOI: 10.1677/joe.0.0880173
© 1981 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MELIN, P.
Right arrow Articles by ÅKERLUND, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MELIN, P.
Right arrow Articles by ÅKERLUND, M.

INHIBITORY EFFECT OF O-ALKYLATED ANALOGUES OF OXYTOCIN AND VASOPRESSIN ON HUMAN AND RAT MYOMETRIAL ACTIVITY

P. MELIN, H. VILHARDT, G. LINDEBERG, L.-E. LARSSON and M. ÅKERLUND

Analogues of oxytocin and vasopressin modified through O-alkylation (methyl, ethyl and butyl) at position 2 of the peptide chain were synthesized and tested for effects on the rat uterus in vivo and on isolated rat and human myometrial preparations. None of the analogues showed any appreciable oxytocic activity. When tested together with oxytocin or vasopressin the analogues inhibited the uterine response to the hormones in a dose-dependent and reversible way. Ethyl-analogues were more powerful antagonists than methyl-analogues but further prolongation of the alkyl-chain (butyl) diminished the antagonistic properties of the compounds. The effect on antagonistic potency of deamination at position 1 of the analogues varied among the analogues and depended on the test system used. The possible clinical value of the antagonists is discussed.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the Society for Endocrinology.